Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review
Background: The literature reports conflicting results regarding the effect of human papillomavirus (HPV) genotype 16 (HPV-16)/18 (HPV-18) positivity on cervical cancer (CC) prognosis.Aim: To conduct a meta-analysis to examine the effect of HPV-16/18 positivity on the prognosis of patients with CC.M...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01733/full |
id |
doaj-318f35ce5d41479eb83b61834b745c8c |
---|---|
record_format |
Article |
spelling |
doaj-318f35ce5d41479eb83b61834b745c8c2020-11-25T03:05:19ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-10-011010.3389/fonc.2020.01733557475Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic ReviewXing Chen0Ping Zhang1Shanshan Chen2Hanxiao Zhu3Kai Wang4Liya Ye5Jun Wang6Junhui Yu7Shuangshuang Mei8Zhengrong Wang9Xiaodong Cheng10Zhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Cancer Hospital, University of Chinese Academy of Sciences, Hangzhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaWomen's Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaBackground: The literature reports conflicting results regarding the effect of human papillomavirus (HPV) genotype 16 (HPV-16)/18 (HPV-18) positivity on cervical cancer (CC) prognosis.Aim: To conduct a meta-analysis to examine the effect of HPV-16/18 positivity on the prognosis of patients with CC.Methods: PubMed, Embase, and the Cochrane Library were searched for available papers published up to March 2020. The main outcome was the hazard ratio (HR) of overall survival (OS) or disease-free survival (DFS) comparing HPV-16 or HPV-18 positivity and negativity. The random-effects model was used for synthesizing survival outcomes.Results: Nine studies and 2,028 patients were included. Four studies reported OS in HPV-16 positivity, and no association was found between HPV-16 positivity and OS to CC (HR = 0.79, 95% CI: 0.26–2.39, P = 0.675). Three studies reported DFS in HPV-16 positivity, and no association was found between HPV-16 positivity and DFS to CC (HR = 0.80, 95% CI: 0.30–2.11, P = 0.654). Two studies reported DFS in HPV-18 positivity, and no association was found between HPV-18 positivity and DFS to CC (HR = 0.99, 95% CI: 0.55–1.78, P = 0.984). One study reported progression-free survival (PFS) in HPV-18 positivity, and an association was observed between HPV-18 positivity and PFS to CC (HR = 2.66, 95% CI: 1.44–4.94, P = 0.002). The sensitivity analyses showed that one study biased the analysis of the association between HPV-16 and OS, and another study biased the association between HPV-16 and DFS.Conclusion: The presence of HPV-16 and HPV-18 positivity appears to have no significant association with prognosis in CC in either OS or PFS. The presence of HPV-16 or HPV-18 positivity has no significant association with prognosis in CC in either OS or PFS.https://www.frontiersin.org/article/10.3389/fonc.2020.01733/fullhuman papillomavirus 16human papillomavirus 18uterine cervical neoplasmsprognosismeta-analysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xing Chen Ping Zhang Shanshan Chen Hanxiao Zhu Kai Wang Liya Ye Jun Wang Junhui Yu Shuangshuang Mei Zhengrong Wang Xiaodong Cheng |
spellingShingle |
Xing Chen Ping Zhang Shanshan Chen Hanxiao Zhu Kai Wang Liya Ye Jun Wang Junhui Yu Shuangshuang Mei Zhengrong Wang Xiaodong Cheng Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review Frontiers in Oncology human papillomavirus 16 human papillomavirus 18 uterine cervical neoplasms prognosis meta-analysis |
author_facet |
Xing Chen Ping Zhang Shanshan Chen Hanxiao Zhu Kai Wang Liya Ye Jun Wang Junhui Yu Shuangshuang Mei Zhengrong Wang Xiaodong Cheng |
author_sort |
Xing Chen |
title |
Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review |
title_short |
Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review |
title_full |
Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review |
title_fullStr |
Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review |
title_full_unstemmed |
Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review |
title_sort |
better or worse? the independent prognostic role of hpv-16 or hpv-18 positivity in patients with cervical cancer: a meta-analysis and systematic review |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2020-10-01 |
description |
Background: The literature reports conflicting results regarding the effect of human papillomavirus (HPV) genotype 16 (HPV-16)/18 (HPV-18) positivity on cervical cancer (CC) prognosis.Aim: To conduct a meta-analysis to examine the effect of HPV-16/18 positivity on the prognosis of patients with CC.Methods: PubMed, Embase, and the Cochrane Library were searched for available papers published up to March 2020. The main outcome was the hazard ratio (HR) of overall survival (OS) or disease-free survival (DFS) comparing HPV-16 or HPV-18 positivity and negativity. The random-effects model was used for synthesizing survival outcomes.Results: Nine studies and 2,028 patients were included. Four studies reported OS in HPV-16 positivity, and no association was found between HPV-16 positivity and OS to CC (HR = 0.79, 95% CI: 0.26–2.39, P = 0.675). Three studies reported DFS in HPV-16 positivity, and no association was found between HPV-16 positivity and DFS to CC (HR = 0.80, 95% CI: 0.30–2.11, P = 0.654). Two studies reported DFS in HPV-18 positivity, and no association was found between HPV-18 positivity and DFS to CC (HR = 0.99, 95% CI: 0.55–1.78, P = 0.984). One study reported progression-free survival (PFS) in HPV-18 positivity, and an association was observed between HPV-18 positivity and PFS to CC (HR = 2.66, 95% CI: 1.44–4.94, P = 0.002). The sensitivity analyses showed that one study biased the analysis of the association between HPV-16 and OS, and another study biased the association between HPV-16 and DFS.Conclusion: The presence of HPV-16 and HPV-18 positivity appears to have no significant association with prognosis in CC in either OS or PFS. The presence of HPV-16 or HPV-18 positivity has no significant association with prognosis in CC in either OS or PFS. |
topic |
human papillomavirus 16 human papillomavirus 18 uterine cervical neoplasms prognosis meta-analysis |
url |
https://www.frontiersin.org/article/10.3389/fonc.2020.01733/full |
work_keys_str_mv |
AT xingchen betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview AT pingzhang betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview AT shanshanchen betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview AT hanxiaozhu betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview AT kaiwang betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview AT liyaye betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview AT junwang betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview AT junhuiyu betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview AT shuangshuangmei betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview AT zhengrongwang betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview AT xiaodongcheng betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview |
_version_ |
1724679158182707200 |